发明名称 感染症治療剤
摘要 Compositions for cancer or infection treatment via immunopotentiation caused by inhibition of immunosuppressive signal induced by PD-1, PD-L1, or PD-L2 and therapies using them, immunopotentiative substrates included as the active ingredient, screening methods of the substrates for cancer or infection treatment, cell lines used for the screening methods, evaluation methods that selects the substrates for cancer treatment, and carcinoma cell transplanted mammals used for the evaluation methods. <??>The compositions of the present invention that inhibits the function of PD-1, PD-L1, or PD-L2 are useful for cancer or infection treatment.
申请公布号 JP5701266(B2) 申请公布日期 2015.04.15
申请号 JP20120197861 申请日期 2012.09.07
申请人 小野薬品工業株式会社;本庶 佑 发明人 本庶 佑;湊 長博;岩井 佳子;柴山 史朗
分类号 A61K39/395;A61K31/7088;A61K35/14;A61K39/29;A61K45/00;A61P1/16;A61P31/00;A61P31/12;A61P35/00;A61P35/04;A61P37/04;A61P37/06;C12Q1/02;G01N33/50;G01N33/574 主分类号 A61K39/395
代理机构 代理人
主权项
地址